JP2009521908A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521908A5
JP2009521908A5 JP2008547861A JP2008547861A JP2009521908A5 JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5 JP 2008547861 A JP2008547861 A JP 2008547861A JP 2008547861 A JP2008547861 A JP 2008547861A JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5
Authority
JP
Japan
Prior art keywords
seq
peptide
nucleic acid
cargo molecule
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008547861A
Other languages
English (en)
Japanese (ja)
Other versions
JP5264502B2 (ja
JP2009521908A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/010271 external-priority patent/WO2007076904A1/en
Publication of JP2009521908A publication Critical patent/JP2009521908A/ja
Publication of JP2009521908A5 publication Critical patent/JP2009521908A5/ja
Application granted granted Critical
Publication of JP5264502B2 publication Critical patent/JP5264502B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008547861A 2005-12-30 2006-10-25 細胞透過性ペプチドとして使用できるペプチド Active JP5264502B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05028755.6 2005-12-30
EP05028755 2005-12-30
PCT/EP2006/010271 WO2007076904A1 (en) 2005-12-30 2006-10-25 Peptides useful as cell-penetrating peptides

Publications (3)

Publication Number Publication Date
JP2009521908A JP2009521908A (ja) 2009-06-11
JP2009521908A5 true JP2009521908A5 (enExample) 2011-06-30
JP5264502B2 JP5264502B2 (ja) 2013-08-14

Family

ID=37491778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547861A Active JP5264502B2 (ja) 2005-12-30 2006-10-25 細胞透過性ペプチドとして使用できるペプチド

Country Status (16)

Country Link
US (3) US20100061932A1 (enExample)
EP (1) EP1966240B3 (enExample)
JP (1) JP5264502B2 (enExample)
KR (1) KR101317100B1 (enExample)
CN (1) CN101395180B (enExample)
AT (1) ATE501169T1 (enExample)
AU (1) AU2006332193B2 (enExample)
BR (1) BRPI0620806B8 (enExample)
CA (1) CA2646833C (enExample)
DE (1) DE602006020617D1 (enExample)
ES (1) ES2361621T7 (enExample)
IL (1) IL192131A (enExample)
MX (1) MX2008008548A (enExample)
PL (1) PL1966240T6 (enExample)
SI (1) SI1966240T1 (enExample)
WO (1) WO2007076904A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005051366A1 (de) 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2090584A1 (en) * 2008-02-13 2009-08-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Identification of a novel cysteine-rich cell penetrating peptide
RU2470666C2 (ru) * 2008-02-28 2012-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для трансназального введения
CN102869384B (zh) 2009-06-22 2016-01-13 伯纳姆医学研究所 使用带有c-端元件的肽和蛋白质的方法和组合物
JP5818319B2 (ja) * 2009-12-14 2015-11-18 国立大学法人北海道大学 脂質膜構造体に細胞透過能を付与および/または脂質膜構造体の細胞透過能を増強するペプチド、ならびにそれらペプチドと結合した脂質を構成脂質として含む、細胞透過能を有するまたは細胞透過能が増強された脂質膜構造体
WO2011084061A1 (en) 2010-01-08 2011-07-14 Universitair Medisch Centrum St. Radboud Cpp (cell penetrating peptide) and its uses
FR2955773B1 (fr) * 2010-02-01 2017-05-26 Commissariat Energie Atomique Complexe moleculaire de ciblage des antigenes vers les cellules presentatrices d'antigene et ses applications pour la vaccination
US9724422B2 (en) * 2010-11-26 2017-08-08 Evonik Roehm Gmbh Human lactoferrin derived peptide for use as an antigen masking agent
CN102174078A (zh) * 2011-01-10 2011-09-07 中国药科大学 肿瘤细胞选择性穿膜肽的应用
CN102091036A (zh) * 2011-01-10 2011-06-15 中国药科大学 一种含有抗肿瘤药物的复合脂质体及其制备方法和用途
CN102153629B (zh) * 2011-01-20 2013-07-24 华中科技大学 一种短肽及其应用
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
EP2715291A4 (en) 2011-05-31 2015-10-21 Airware Inc NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR)
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
CN102988295B (zh) * 2011-09-09 2015-07-29 复旦大学 一种穿膜肽修饰的纳米粒及其制备方法
CN102993296A (zh) * 2011-09-14 2013-03-27 广州格拉姆生物科技有限公司 牛乳铁蛋白肽及其制备方法
WO2013052058A1 (en) * 2011-10-07 2013-04-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
US8669226B2 (en) 2011-10-07 2014-03-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
US12083158B2 (en) 2011-10-07 2024-09-10 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
DE102011055229A1 (de) 2011-11-10 2013-05-16 Evonik Degussa Gmbh Verfahren zur Bereitstellung von Regelleistung mit einem Energiespeicher unter Ausnutzung von Toleranzen bei der Bestimmung der Frequenzabweichung
DE102011055231A1 (de) * 2011-11-10 2013-05-16 Evonik Industries Ag Verfahren zur Bereitstellung von Regelleistung
US9259483B2 (en) 2011-11-24 2016-02-16 Positec Power Tools (Suzhou) Co Ltd Peptide sequence design and use thereof for peptide-mediated siRNA delivery
CN103169982B (zh) * 2011-12-23 2015-05-20 中国科学院上海药物研究所 生物活性肽修饰的纳米银及其制备方法和用途
CN103382217B (zh) * 2012-12-11 2015-05-27 任发政 穿膜肽和药物组合物及其制备方法和应用
US9642895B2 (en) 2013-08-12 2017-05-09 3M Innovative Properties Company Peptides for enhancing transdermal delivery
WO2015075747A1 (en) * 2013-11-19 2015-05-28 Council Of Scientific And Industrial Research Cell-penetrating peptide for biomolecule delivery
WO2015089487A1 (en) 2013-12-12 2015-06-18 Life Technologies Corporation Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
CN103784406A (zh) * 2014-01-20 2014-05-14 同济大学 一种偶联穿膜肽和mmp酶切位点的纳米颗粒
ES2767501T3 (es) * 2014-05-28 2020-06-17 Evonik Operations Gmbh Nanopartícula
US10793603B2 (en) * 2015-02-27 2020-10-06 Josho Gakuen Educational Foundation Polysaccharide derivative having membrane-permeable peptide chain
KR101647804B1 (ko) * 2015-06-24 2016-08-11 한국과학기술연구원 신규 세포투과 펩타이드 및 이의 용도
CN108456254B (zh) * 2017-02-20 2021-06-01 中国科学院上海药物研究所 一种tcs-穿膜肽-肿瘤蛋白酶底物肽融合蛋白、其制备方法和用途
EP3628047A1 (en) 2017-05-02 2020-04-01 Sanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
CN108101966B (zh) * 2017-12-26 2020-10-27 暨南大学 基于细胞穿膜肽的氧化还原敏感多肽及其在疫苗载体中的应用
EP3790534B1 (en) 2018-05-08 2023-08-30 Evonik Operations GmbH Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide
CN111499759B (zh) * 2019-01-31 2022-12-20 上海科技大学 一种具有细胞穿膜性的锌指蛋白-乳铁蛋白融合蛋白质及其制备与应用
EP3921329A1 (en) 2019-02-04 2021-12-15 University of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
CN110078834B (zh) * 2019-05-05 2021-07-30 华中科技大学 一种类短肽、辅助透膜剂及其应用
CN112426438B (zh) * 2019-11-14 2023-12-05 上海鑫湾生物科技有限公司 用于调控酸性环境免疫应答的组合物、其制备方法和用途
BR112022019370A2 (pt) * 2020-03-27 2022-11-29 Alastin Skincare Inc Composições e métodos relativos à pigmentação
IL315874A (en) 2022-03-30 2024-11-01 Evonik Operations Gmbh Formulations consisting of cationic lipids and poly(lactic-co-glycolic acid) for delivery of polynucleotides to cells
EP4601700A1 (en) * 2022-10-13 2025-08-20 Stichting Radboud universitair medisch centrum A complex comprising a cargo and a targeting moiety binding intelectin-1
CN120641131A (zh) 2022-12-01 2025-09-12 耶鲁大学 用于细胞内有效载荷递送的刺激反应性无痕工程化平台

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3207535B2 (ja) * 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
JP2001504448A (ja) 1996-08-30 2001-04-03 フュルステ,イェンス,ペーター 核酸の鏡面対称選択および進化
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US6958239B2 (en) 1996-11-21 2005-10-25 Oligos Etc Inc. Three component chimeric antisense oligonucleotides
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
AU4656999A (en) 1998-07-15 2000-02-07 Samyang Genex Corporation Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof
JP3681982B2 (ja) * 1998-07-15 2005-08-10 サムヤン ジェネックス コーポレイション 酵母からラクトフェリンポリペプチドを大量生産する方法及びそれに有用な微生物菌株
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
EP1309726B2 (en) 2000-03-30 2018-10-03 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference

Similar Documents

Publication Publication Date Title
JP2009521908A5 (enExample)
JP6077543B2 (ja) ペプチド
KR101317100B1 (ko) 세포-침투성 펩티드로서 유용한 펩티드
Zhang et al. Instructive design of triblock peptide amphiphiles for structurally complex micelle fabrication
AU2012303619B2 (en) Pathogen and substance traps
EP2594581A3 (en) Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens
KR20240172763A (ko) 핵산 및/또는 단백질 적재물 전달을 위한 조성물 및 방법
Zhang et al. Recent advances of cell-penetrating peptides and their application as vectors for delivery of peptide and protein-based cargo molecules
KR20180064534A (ko) 조건부 활성 폴리펩티드
JP2013504589A5 (enExample)
CN104736181A (zh) 包含靶向聚氨基酸与脂肪酸之缀合物的药物递送载剂
CN102256999A (zh) 向白细胞的有效转运
WO2008039483A3 (en) Modified self-assembling peptides
JP2014504150A5 (enExample)
Hou et al. Co-delivery of siPTPN13 and siNOX4 via (myo) fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy
KR101647804B1 (ko) 신규 세포투과 펩타이드 및 이의 용도
JP2015522264A5 (enExample)
Platt et al. Stapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptors
JP2025028940A (ja) 界面活性ペプチドナノ構造および薬物送達における使用
JP2008538280A5 (enExample)
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
F Nahhas et al. Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics
JP2022502347A (ja) 細胞透過性ペプチド
CN116724059A (zh) 用于治疗病毒感染的组合物和方法
CN115243699A (zh) 分子导向系统肽及其用途